APHKX | FSQAX | APHKX / FSQAX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 18 years | 3 years | - |
Gain YTD | 8.661 | 7.345 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 35B | 10.7M | 327,103% |
Annual Yield % from dividends | 1.21 | 1.27 | 95% |
Returns for 1 year | 12.74 | 16.09 | 79% |
Returns for 3 years | 19.62 | N/A | - |
Returns for 5 years | 46.98 | N/A | - |
Returns for 10 years | 52.78 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
AATSX | 21.29 | -0.08 | -0.37% |
Ancora/Thelen Small-Mid Cap S | |||
APLIX | 11.44 | -0.11 | -0.95% |
Cavanal Hill Hedged Income Investor | |||
SBMLX | 24.86 | -0.26 | -1.04% |
ClearBridge Mid Cap C | |||
EIDIX | 16.97 | -0.23 | -1.34% |
Eaton Vance Global Equity Income I | |||
BHSRX | 64.71 | -1.57 | -2.37% |
BlackRock Health Sciences Opps R |